The laboratory diagnosis of Chlamydia trachomatis infections

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 16, Issue 1, 2005, Pages 39-44

  Chernesky, Max A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Antigen detection; Appropriate specimens; Cell culture; Diagnostic methods; Nucleic acid amplification

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; OFLOXACIN; RIFAMPICIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CYTOLOGY; GENITAL TRACT INFECTION; HUMAN; LABORATORY DIAGNOSIS; LYMPHOGRANULOMA VENEREUM; MICROSCOPY; NUCLEIC ACID ANALYSIS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REVIEW; SEMEN ANALYSIS; SERODIAGNOSIS; TRACHOMA; URINALYSIS;

EID: 16344387743     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/359046     Document Type: Review

References (33)

1. Schachter J. Chlamydial infections. N Engl J Med 1978;298:428-35, 490-5,540-9.
2. Beem MO, Saxon EM. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis. N Engl J Med 1977;296:306-10.
3. Wasserheit JN. Effect of changes in human ecology and behavior on patterns of sexually transmitted diseases, including human immunodeficiency virus infection. Proc Natl Acad Sci USA 1994;91:2430-5.
4. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998;128:277-84.
5. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis 1997;24:131-41.
6. Mahony JB, Chernesky MA. Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens. J Clin Microbiol 1985;22:865-7.
7. Chernesky MA, Jang D, Lee H, et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first void urine with ligase chain reaction. J Clin Microbiol 1994;32:2682-5.
8. Stary A, Najim B, Lee HH. Vulval swabs as alternative specimens for ligase chain reaction detection of genital chlamydial infection in women. J Clin Microbiol 1997;35:836-8.
9. Wiesenfeld HC, Heine RP, Rideout A, Macio I, DiBiasi F, Sweet RL. The vaginal introitus: A novel site for Chlamydia trachomatis testing in women. Am J Obstet Gynecol 1996;174:1542-6.
10. Schachter J, McCormack WM, Chernesky MA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 2003;41:3784-9.
11. Chernesky M, Luinstra K, Sellors J, et al. Can serology diagnose upper genital tract Chlamydia trachomatis infections? Studies on women with pelvic pain, with or without chlamydial plasmid DNA in endometrial biopsy tissue. Sex Transm Dis 1998;25:14-9.
12. Ripa KT, Mardh PA. Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells. J Clin Microbiol 1977;6:328-31.
13. Chernesky MA, Mahony JB, Castriciano S, et al. Detection of Chlamydia trachomatis antigens by enzyme immunoassay and immunofluorescence in genital specimens from symptomatic and asymptomatic men and women. J Infect Dis 1986;154:141-8.
14. Moncada J, Schachter J, Bolan G, et al. Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1990;28:1770-3.
15. Cles LD, Bruch K, Stamm WE. Staining characteristics of six commercially available monoclonal immunofluorescence reagents for direct diagnosis of Chlamydia trachomatis infections. J Clin Microbiol 1988;26:1735-7.
16. Gift TL, Pate MS, Hook EW 3rd, Kassler WJ. The rapid test paradox: When fewer cases detected lead to more cases treated. Sex Transm Dis 1999;26:232-40.
17. Clarke LM, Sierra MF, Daidone BJ, Lopez N, Covino JM, McCormack WM. Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol 1993;31:968-71.
18. Schachter J, Hook EW 3rd, McCormack WM, et al. Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol 1999;37:3668-71.
19. Mahony J, Chong S, Jang D, et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998;36:3122-6.
20. Kluytmans JA, Goessens WH, Mouton JW, et al. Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1993;31:3204-10.
21. Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests. J Clin Microbiol 2001;39:1751-6.
22. Kapala J, Copes D, Sproston A, et al. Pooling cervical swabs and testing by ligase chain reaction are accurate and cost-saving strategies for diagnosis of Chlamydia trachomatis. J Clin Microbiol 2000;38:2480-3.
23. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR Recomm Rep 2002;51:1-38.
24. Wang SP, Grayston JT. Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis 1974;130:388-97.
25. Conway D, Glazener CM, Caul EO, et al. Chlamydial serology in fertile and infertile women. Lancet 1984;1:191-3.
26. Richmond SJ, Caul EO. Fluorescent antibody studies in chlamydial infections. J Clin Microbiol 1975;1:345-52.
27. Jones RB, Van der Pol B, Martin DH, Shepard MK. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis 1990;162:1309-15.
28. Lefevre JC, Lepargneur JP. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France). Sex Transm Dis 1998;25:350-2.
29. Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000;181:1421-7.
30. Ehret JM, Judson FN. Susceptibility testing of Chlamydia trachomatis: From eggs to monoclonal antibodies. Antimicrob Agents Chemother 1988;32:1295-9.
31. Cross NA, Kellock DJ, Kinghorn GR, et al. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. Antimicrob Agents Chemother 1999;43:2311-3.
32. Wiedbrauk DL, Stoerker J. Quality assurance in the molecular virology laboratory. In: Wiedbrauk DL, Farkas DH, eds. Molecular Methods for Virus Detection. San Diego: Academic Press, 1995:25-37.
33. Chernesky MA, Mahony JB. Molecular diagnosis of Chlamydia trachomatis infections by probe hybridization, PCR, LCR, TMA and Q-beta replicase. In: Peeling RW, Sparling PF, eds. Sexually Transmitted Diseases: Methods and Protocols. New Jersey: Humana Press, 1999:33-46.